PhD Position in Cancer Glycobiology laboratory at CIC bioGUNE

2025/05/07

We seek a motivated PhD candidate to join “PreMetaCan AECC”, a cutting-edge project on cancer metabolism and precision medicine, working under the supervision of Dr. June Ereño-Orbea and Dr. Marco Piva at CIC bioGUNE, a Severo Ochoa Excellence research center in Bilbao, Basque Country, Spain. This position is part of a prestigious €2M Scientific Foundation of the Spanish Association Against Cancer (AECC) Excellence grant aimed at tackling systemic tumor-host metabolic interactions to advance precision oncology. We welcome applications from motivated young scientists with strong background in cellular and molecular biology. Candidates with experience in glycobiology, biochemistry, or structural biology are particularly encouraged to apply. Given the nature of the project, training in immunology is an advantage. Applicants should be willing to be trained in a highly collaborative environment within a multidisciplinary team. The selected candidate will join a fully funded 4-year PhD project, supported by the AECC Excellence Program, focused on deciphering the glycan landscape of tumor cells and the tumor microenvironment across various pathological contexts to uncover novel therapeutic targets. This position offers a unique opportunity to engage in cutting-edge research in cancer glycobiology, while receiving multidisciplinary training in glycosciences, structural biology, and AI-based analytical tools. The candidate will gain hands-on experience with both in vitro and in vivo models and benefit from access to state-of-the-art facilities. The research will be conducted at CIC bioGUNE, a leading international center in biosciences, within a dynamic and collaborative environment. Application procedure: Motivated candidates should submit an application package including (i) a detailed CV, (ii) a cover letter, and (iii) contact details for references. Applications should be submitted via the form available at form and indicating 42201 as reference.